Doxycycline Use in Patients with Inherited Muscle Metabolism Deficiencies

General Considerations

Doxycycline is a tetracycline antibiotic that inhibits the production and activity of matrix metalloproteinases (MMPs), including MMP-2 and MMP-9, which may have implications for muscle pathology 1, 2
Standard dosing for adults and children (12-17 years) is 100 mg twice daily orally, taken with a full glass of water to reduce the risk of esophagitis and esophageal ulceration 3, 4
Routine toxicity monitoring tests (FBC, U&Es, LFTs) should be performed intermittently throughout antibiotic treatment 3, 4

Doxycycline may cause myasthenia gravis exacerbation due to its potential for weak neuromuscular blockade, which is particularly relevant for patients with muscle metabolism disorders 3, 4
Common adverse effects include gastrointestinal symptoms (nausea, vomiting, diarrhea, dysphagia) and dermatological reactions (photosensitivity, rash) 3, 4
Serious adverse effects can include hepatotoxicity, which may be of particular concern in patients with metabolic disorders that may already affect liver function 3, 4

Baseline and periodic monitoring of liver function tests is essential, especially in patients with underlying liver disease 3, 4
Be vigilant for drug interactions, particularly with medications commonly used in metabolic disorders 3, 4

Before initiating therapy, review concomitant medications for potential interactions 3, 4
During therapy, start with standard dosing unless renal or hepatic impairment is present, and monitor for both improvement in muscle symptoms and potential adverse effects 3, 4
Perform regular laboratory monitoring (FBC, U&Es, LFTs) 3, 4
Avoid in children under 12 years due to risk of permanent teeth discoloration and enamel hypoplasia 3, 4
Use with caution in patients with porphyria, which may be associated with some metabolic myopathies 3, 4

The Centers for Disease Control and Prevention recommends avoiding doxycycline in children under 8 years of age due to the risk of permanent teeth discoloration 5
The Centers for Disease Control and Prevention contraindicates doxycycline in pregnancy and nursing women 6

For tickborne rickettsial diseases, when tetracycline allergy exists or is contraindicated, the Centers for Disease Control and Prevention may consider chloramphenicol as an alternative 5, 6
For mild anaplasmosis during pregnancy, the Infectious Diseases Society of America could consider rifampin as an alternative 5
For blepharitis and other conditions, the American Academy of Ophthalmology may use macrolides, such as erythromycin or azithromycin, as alternatives 7

The Centers for Disease Control and Prevention suggests assessing the necessity of antibiotic therapy and considering non-tetracycline alternatives first 6